Rogers Alice R, Jenkins Bethan
Department of Dietetics and Speech Therapy, University Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, UK.
J Intensive Care Soc. 2021 Aug;22(3):183-186. doi: 10.1177/1751143720937451. Epub 2020 Jun 26.
Citrate is used as a regional anticoagulant for continuous veno-venous haemofiltration and provides 0.59 kcal/mmol. Previous studies hypothesised continuous veno-venous haemofiltration can provide 200-1300 kcal/day dependent on the anticoagulant and replacement solutions used. The aim of this study was to calculate the calorie load from citrate in our patient group.
An equation derived from a paper by Oudemans-van Straaten was used to estimate calorie provision from citrate. Citrate calorie load was defined as the difference between the citrate in the filter circuit and the removal by continuous veno-venous haemofiltration. Clinical data were recorded on 20 consecutive patients admitted to intensive care unit and commenced on citrate continuous veno-venous haemofiltration using prismacitrate 18/0 by Gambro, a tri-sodium citrate solution. Clinical data recorded included patient demographics, filter settings including blood flow, filtration factor, citrate dose and time on filtration daily.
A total of 20 critically ill patients received continuous veno-venous haemofiltration for treatment of a new acute kidney injury, mean age 66 years, 65% male. Mean duration of continuous veno-venous haemofiltration was 3.7 days. Mean daily time on filtration was 20 h/day. Mean filtration fraction, citrate dose and blood flow were 30%, 3 mmol/L and 123 ml/min, respectively. Our calculation showed that a mean of 9.5 ± 1.7 cal/h were provided from citrate with a mean daily calorie load of 196 ± 69 kcal.
Continuous veno-venous haemofiltration with tri-sodium citrate provided an additional 196 ± 69 kcal/day. The calorie load from citrate continuous veno-venous haemofiltration should be calculated regularly as changes in filter settings, in particular citrate dose and blood flow can have a significant impact on calorie provision.
枸橼酸盐用作连续性静脉-静脉血液滤过的局部抗凝剂,每毫摩尔提供0.59千卡热量。既往研究推测,根据所使用的抗凝剂和置换液不同,连续性静脉-静脉血液滤过每天可提供200-1300千卡热量。本研究的目的是计算我们患者群体中枸橼酸盐的热量负荷。
采用Oudemans-van Straaten一篇论文中推导的公式来估算枸橼酸盐提供的热量。枸橼酸盐热量负荷定义为滤器回路中的枸橼酸盐量与连续性静脉-静脉血液滤过清除量之间的差值。记录了20例连续入住重症监护病房并开始使用Gambro公司的18/0聚明胶肽(一种枸橼酸钠溶液)进行枸橼酸盐连续性静脉-静脉血液滤过的患者的临床数据。记录的临床数据包括患者人口统计学资料、滤器设置,包括血流量、滤过分数、枸橼酸盐剂量以及每日滤过时间。
共有20例危重症患者接受连续性静脉-静脉血液滤过来治疗新发急性肾损伤,平均年龄66岁,65%为男性。连续性静脉-静脉血液滤过的平均持续时间为3.7天。平均每日滤过时间为20小时/天。平均滤过分数、枸橼酸盐剂量和血流量分别为30%、3毫摩尔/升和123毫升/分钟。我们的计算表明,枸橼酸盐平均每小时提供9.5±1.7千卡热量,平均每日热量负荷为196±69千卡。
使用枸橼酸钠进行连续性静脉-静脉血液滤过每天可额外提供196±69千卡热量。应定期计算枸橼酸盐连续性静脉-静脉血液滤过的热量负荷,因为滤器设置的变化,尤其是枸橼酸盐剂量和血流量的变化,可能会对热量供应产生重大影响。